Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microparticles for intranasal immunization.

M Vajdy1, D T O'Hagan

  • 1Chiron Vaccines, 4560 Horton Street, Emeryville, CA 94608, USA. michael_vajdy@cc.chiron.com

Advanced Drug Delivery Reviews
|August 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs.

Vaccine·2013
Same author

The mechanism of action of MF59 - an innately attractive adjuvant formulation.

Vaccine·2012
Same author

MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development?

Clinical pharmacology and therapeutics·2007
Same author

Long-term protection in hamsters against human parainfluenza virus type 3 following mucosal or combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles.

Scandinavian journal of immunology·2007
Same author

Delivery systems and adjuvants for oral vaccines.

Expert opinion on drug delivery·2006
Same author

Generation and maintenance of mucosal memory B cell responses?

Current medicinal chemistry·2006
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Nasal immunization using microparticles offers a promising approach for vaccines. Poly(lactide co-glycolide) (PLG) microparticles effectively deliver protein and DNA vaccines, enhancing immune responses for mucosal immunization.

Area of Science:

  • Immunology
  • Vaccinology
  • Biomaterials

Background:

  • Mucosal immunization, particularly via the nasal route, is attractive for its ease of administration and ability to induce potent immune responses in the respiratory and genitourinary tracts.
  • Enhancing immune responses following nasal immunization often requires the use of adjuvants and specialized delivery systems.
  • Microparticles are emerging as effective tools for both adjuvant and delivery functions in nasal vaccine strategies.

Purpose of the Study:

  • To review the application of microparticles as adjuvants and delivery systems for nasal immunization with protein and DNA vaccines.
  • To highlight research utilizing poly(lactide co-glycolide) (PLG) microparticles for entrapped protein or adsorbed DNA vaccine delivery.
  • To discuss potential mechanisms underlying the enhanced immune responses induced by DNA adsorbed onto PLG microparticles.

Related Experiment Videos

Main Methods:

  • Review of scientific literature on microparticle-based nasal vaccine delivery.
  • Focus on studies involving poly(lactide co-glycolide) (PLG) microparticles.
  • Discussion of experimental data concerning protein and DNA vaccine entrapment/adsorption onto PLG microparticles.

Main Results:

  • Poly(lactide co-glycolide) (PLG) microparticles serve as effective delivery systems for both protein and DNA vaccines via the nasal route.
  • Nasal immunization with PLG-encapsulated or adsorbed vaccines can significantly enhance immune responses.
  • Specific mechanisms contributing to immune enhancement by DNA adsorbed onto PLG microparticles are explored.

Conclusions:

  • Microparticles, particularly PLG-based systems, represent a viable strategy for improving nasal vaccine efficacy.
  • The use of PLG microparticles facilitates the delivery of diverse vaccine types (protein and DNA) for mucosal immunization.
  • Further investigation into the mechanisms of action is crucial for optimizing microparticle-based nasal vaccine development.